Volume 16, Number 1—January 2010
Dispatch
Reemergence of Syphilis in Martinique, 2001–2008
Table 2
Incidence of syphilis, Fort-de-France, Martinique, 2000–2007*
| Characteristic | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 |
|---|---|---|---|---|---|---|---|---|
| HIV-infected patients at University Hospital | ||||||||
| Total no. patients | 479 | 492 | 508 | 544 | 564 | 659 | 724 | 746 |
| MSM, no. (%) | 107 (22) | 108 (22) | 110 (22) | 126 (23) | 124 (22) | 160 (24) | 184 (25) | 185 (25) |
| Incidence of recent syphilis/ 1,000 patient-years, % | 0 | 0 | 0 | 0 | 5.3 | 15.2 | 9.6 | 12.1 |
| Incidence of recent syphilis/
1,000 patient-years in MSM, % |
0 |
0 |
0 |
0 |
24.2 |
31.2 |
21.7 |
27.1 |
| Vernes STD Clinic | ||||||||
| Syphilis tests, no. | 306 | 559 | 1,368 | 1,478 | 1,266 | 1,081 | 976 | 1,592 |
| Recent syphilis, no. |
0 |
1 |
2 |
3 |
0 |
0 |
3 |
4 |
| A-VCT clinics | ||||||||
| Syphilis tests, no. | ND | ND | 93 | 821 | 651 | 1,186 | 709 | 1,159 |
| Recent syphilis, no. |
ND |
ND |
0 |
1 |
2 |
4 |
2 |
3 |
| University Hospital central laboratory | ||||||||
| Syphilis tests, no. | 2,053 | 1,755 | 1,876 | 2,575 | 2,387 | 3,187 | 2,050 | 3,225 |
| TPHA titer >80, no. (%) | 189 (9.2) | 171 (9.7) | 182 (9.7) | 235 (9.1) | 200 (8.3) | 258 (8.1) | 114 (5.6) | 217 (6.7) |
| RPR test titer >4/TPHA titer >80,† % | 1.6 | 1.8 | 2.2 | 2.1 | 5.0 | 7.0 | 11.4 | 11.6 |
| RPR test titer >8/TPHA titer >80, % |
1.1 |
0.6 |
1.1 |
0.9 |
3.5 |
6.6 |
8.8 |
9.7 |
| Blood donors | ||||||||
| Syphilis tests, no. | 8,161 | 8,315 | 8,638 | 8,914 | 8,993 | 8,057 | 9,199 | 8,495 |
| TPHA titer >80, no. (%) | 45 (0.6) | 49 (0.6) | 39 (0.5) | 42 (0.5) | 30 (0.3) | 31 (0.4) | 33 (0.4) | 27 (0.3) |
| RPR test titer ≥1, no. (%) | 10 (0.1) | 26 (0.3) | 11 (0.1) | 12 (0.1) | 5 (0.06) | 5 (0.06) | 4 (0.04) | 4 (0.05) |
| RPR test titer >4, no. (%) | 1 (0.01) | 1 (0.01) | 1 (0.01) | 1 (0.01) | 0 | 0 | 1 (0.01) | 0 |
| RPR test titer >4/TPHA titer >80,† % | 2.2 | 2.0 | 2.6 | 2.4 | 0 | 0 | 3.0 | 0 |
*MSM, men who have sex with men; STD, sexually transmitted disease; A-VCT, anonymous voluntary counseling and testing; TPHA, Treponema pallidum hemaglutination assay; RPR, rapid plasma reagin;
†Defines active syphilis.


